Nuveen Asset Management, LLC Myovant Sciences Ltd. Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$7.78 - $14.69 $374,365 - $706,868
48,119 New
48,119 $598,000
Q3 2021

Nov 12, 2021
SELL
$18.94 - $26.99 $1.25 Million - $1.78 Million
-65,856 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$17.07 - $24.56 $1.12 Million - $1.62 Million
65,856 New
65,856 $1.5 Million

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email